Shanghai No 1 Pharmacy Co (SHSE:600833) Other Operating Expense: ¥260 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600833 Shanghai No 1 Pharmacy Co Ltd SHSE:600833
58 GF Score
Price ¥11.03
GF Value ¥12.97
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Shanghai No 1 Pharmacy Co Other Operating Expense?

Shanghai No 1 Pharmacy Co SHSE:600833 +2.32% 58 Other Operating Expense is ¥260 Mil as of Jun. 2026. GuruFocus rates SHSE:600833 with a GF Score™ of 58/100 and a GF Value™ of ¥12.97 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Shanghai No 1 Pharmacy Co's Other Operating Expense for the three months ended in Jun. 2026 was ¥123 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 was ¥260 Mil.

Shanghai No 1 Pharmacy Co's quarterly Other Operating Expense declined from Dec. 2025 (¥261 Mil) to Mar. 2026 (¥1 Mil) but then increased from Mar. 2026 (¥1 Mil) to Jun. 2026 (¥123 Mil).

Shanghai No 1 Pharmacy Co's annual Other Operating Expense increased from Dec. 2023 (¥259 Mil) to Dec. 2024 (¥262 Mil) and increased from Dec. 2024 (¥262 Mil) to Dec. 2025 (¥265 Mil).

Shanghai No 1 Pharmacy Co Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Shanghai No 1 Pharmacy Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai No 1 Pharmacy Co Other Operating Expense Chart

Shanghai No 1 Pharmacy Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 202.59 257.62 259.23 262.25 264.67

Shanghai No 1 Pharmacy Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 127.75 -125.71 261.14 0.79 123.33
SHSE:600833
58GF Score
Shanghai No 1 Pharmacy Co Ltd SHSE:600833
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai No 1 Pharmacy Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥260 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of ¥260 Mil mean?
Shanghai No 1 Pharmacy Co (SHSE:600833) has a Other Operating Expense of ¥260 Mil as of Jun. 2026. Other operating expenses that a company records on its income statement. View historical data on Shanghai No 1 Pharmacy Co and its competitors.
Is Shanghai No 1 Pharmacy Co's Other Operating Expense too high?
Shanghai No 1 Pharmacy Co's current Other Operating Expense is ¥260 Mil. Overall, Shanghai No 1 Pharmacy Co has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai No 1 Pharmacy Co's Other Operating Expense compare to competitors?
Shanghai No 1 Pharmacy Co's Other Operating Expense of ¥260 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Healthcare Providers & Services company?
A good Other Operating Expense depends on the Healthcare Providers & Services industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Shanghai No 1 Pharmacy Co and its competitors. Shanghai No 1 Pharmacy Co's current Other Operating Expense is ¥260 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai No 1 Pharmacy Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai No 1 Pharmacy Co (SHSE:600833) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥12.97, compared to a current price of ¥11.03 — trading 15% below its estimated fair value. The current Other Operating Expense is ¥260 Mil. Shanghai No 1 Pharmacy Co's overall GF Score™ is 58/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Shanghai No 1 Pharmacy Co (SHSE:600833), the current Other Operating Expense is ¥260 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai No 1 Pharmacy Co (SHSE:600833) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai No 1 Pharmacy Co stock appears to be undervalued. The current stock price of ¥11.03 is trading 15% below its estimated GF Value™ of ¥12.97. GuruFocus considers Shanghai No 1 Pharmacy Co to be Modestly Undervalued.

Key valuation signals for SHSE:600833:

  • Other Operating Expense: ¥260 Mil
  • GF Value™: ¥12.97 vs. price of ¥11.03 (15% below fair value)
  • GF Score™: 58/100 with 6 warning signs

No single metric tells the full story. See the SHSE:600833 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai No 1 Pharmacy Co Business Description

Address No. 616 Nanjing East Road, Huangpu District, Shanghai, CHN, 200032
Shanghai No 1 Pharmacy Co Ltd is engaged in pharmaceutical retail and wholesale in China. The company's product profile include Lei Shi Pearl Powder, Tongrentang Ejiao Powder, Wanshuntang Yangyin mouth fragrance mixture, and others. It also provides Nourishing health Nutrition, Medical instruments, Rehabilitation care, Contact lens, and others.
58GF Score

Get the complete analysis for SHSE:600833

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥11.03
Price
¥12.97
GF Value